Actively Recruiting

Phase 3
Age: 18Years +
All Genders
NCT06692738

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Led by AstraZeneca · Updated on 2026-05-01

880

Participants Needed

301

Research Sites

255 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the first-line (1L) treatment of patients with metastatic squamous non-small cell lung cancer (mNSCLC) whose tumors express programmed death-ligand 1 (PD-L1).

CONDITIONS

Official Title

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Histologically or cytologically documented squamous NSCLC.
  • Stage IV mNSCLC (based on the American Joint Committee on Cancer Edition 8) not amenable to curative treatment.
  • Absence of documented tumor genomic mutation results from tests conducted as part of standard local practice in any actionable driver oncogenes for which there are locally approved targeted 1L therapies.
  • Provision of acceptable tumor sample to confirm tumor PD-L1 expression TC ≥ 1%.
  • At least one lesion not previously irradiated that qualifies as a RECIST 1.1 TL at baseline and can be accurately measured at baseline as ≥ 10 mm in the longest diameter (except lymph nodes, which must have short axis ≥ 15 mm) with CT or MRI and is suitable for accurate repeated measurements.
  • Adequate organ and bone marrow function.
Not Eligible

You will not qualify if you...

  • Presence of small cell and neuroendocrine histology components.
  • Brain metastases unless asymptomatic, stable, and not requiring steroids or anticonvulsants for at least 7 days prior to randomization. A minimum of 2 weeks must have elapsed between the end of local therapy (brain radiotherapy or surgery) and randomization. Participants must have recovered from the acute toxic effect of radiotherapy (eg, dizziness and signs of increased intracranial pressure) or surgery prior to randomization.
  • Any prior systemic therapy received for advanced or mNSCLC.
  • Any prior treatment with an anti-PD-1 or anti-PD-L1 agent.
  • Any prior exposure to an anti-TIGIT therapy or any other anticancer therapy targeting immune-regulatory receptors or mechanisms.
  • History of another primary malignancy except for malignancy treated with curative intent with no known active disease ≥ 2 years before the first dose of study intervention and of low potential risk for recurrence.
  • Active or prior documented autoimmune or inflammatory disorders requiring chronic treatment with steroids or other immunosuppressive treatment.
  • Active primary immunodeficiency/active infectious disease(s).
  • Active tuberculosis infection.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 301 locations

1

Research Site

Tucson, Arizona, United States, 85724

Actively Recruiting

2

Research Site

Springdale, Arkansas, United States, 72762

Actively Recruiting

3

Research Site

Anaheim, California, United States, 92801

Actively Recruiting

4

Research Site

Beverly Hills, California, United States, 90211

Actively Recruiting

5

Research Site

Loma Linda, California, United States, 92354

Actively Recruiting

6

Research Site

Los Alamitos, California, United States, 90720

Actively Recruiting

7

Research Site

Redlands, California, United States, 92373

Actively Recruiting

8

Research Site

San Francisco, California, United States, 94121

Actively Recruiting

9

Research Site

Walnut Creek, California, United States, 94598

Actively Recruiting

10

Research Site

West Haven, Connecticut, United States, 06516

Actively Recruiting

11

Research Site

Newark, Delaware, United States, 19713

Actively Recruiting

12

Research Site

Bay Pines, Florida, United States, 33744

Actively Recruiting

13

Research Site

Fort Lauderdale, Florida, United States, 33308

Actively Recruiting

14

Research Site

Gainesville, Florida, United States, 32608

Actively Recruiting

15

Research Site

Gainesville, Florida, United States, 32610

Withdrawn

16

Research Site

Jacksonville, Florida, United States, 32224

Actively Recruiting

17

Research Site

Athens, Georgia, United States, 30607

Actively Recruiting

18

Research Site

Atlanta, Georgia, United States, 30341

Withdrawn

19

Research Site

Boise, Idaho, United States, 83712

Actively Recruiting

20

Research Site

Chicago, Illinois, United States, 60637

Actively Recruiting

21

Research Site

Decatur, Illinois, United States, 62526

Actively Recruiting

22

Research Site

Hinsdale, Illinois, United States, 60521

Actively Recruiting

23

Research Site

Quincy, Illinois, United States, 62301

Actively Recruiting

24

Research Site

Rockford, Illinois, United States, 61114

Not Yet Recruiting

25

Research Site

Waterloo, Iowa, United States, 50702

Actively Recruiting

26

Research Site

Lexington, Kentucky, United States, 40509

Actively Recruiting

27

Research Site

Lexington, Kentucky, United States, 40536

Withdrawn

28

Research Site

Louisville, Kentucky, United States, 40202

Actively Recruiting

29

Research Site

Louisville, Kentucky, United States, 40207

Actively Recruiting

30

Research Site

Alexandria, Louisiana, United States, 71301

Withdrawn

31

Research Site

Baton Rouge, Louisiana, United States, 70808

Actively Recruiting

32

Research Site

Covington, Louisiana, United States, 70433

Withdrawn

33

Research Site

Shreveport, Louisiana, United States, 71103

Actively Recruiting

34

Research Site

Shreveport, Louisiana, United States, 71105

Actively Recruiting

35

Research Site

South Portland, Maine, United States, 04106

Actively Recruiting

36

Research Site

Baltimore, Maryland, United States, 21202

Actively Recruiting

37

Research Site

Bethesda, Maryland, United States, 20817

Actively Recruiting

38

Research Site

Detroit, Michigan, United States, 48202

Actively Recruiting

39

Research Site

Grand Rapids, Michigan, United States, 49503

Actively Recruiting

40

Research Site

Duluth, Minnesota, United States, 55802

Actively Recruiting

41

Research Site

Rochester, Minnesota, United States, 55905

Actively Recruiting

42

Research Site

Bridgeton, Missouri, United States, 63044

Actively Recruiting

43

Research Site

Columbia, Missouri, United States, 65212

Withdrawn

44

Research Site

Kansas City, Missouri, United States, 64108

Actively Recruiting

45

Research Site

Lincoln, Nebraska, United States, 68506

Actively Recruiting

46

Research Site

Camden, New Jersey, United States, 08103

Actively Recruiting

47

Research Site

Buffalo, New York, United States, 14221

Actively Recruiting

48

Research Site

East Syracuse, New York, United States, 13057

Actively Recruiting

49

Research Site

Westbury, New York, United States, 11590

Actively Recruiting

50

Research Site

Grand Forks, North Dakota, United States, 58201

Actively Recruiting

51

Research Site

Canton, Ohio, United States, 44718

Not Yet Recruiting

52

Research Site

Cincinnati, Ohio, United States, 45267

Actively Recruiting

53

Research Site

Bend, Oregon, United States, 97701

Withdrawn

54

Research Site

Medford, Oregon, United States, 97504

Actively Recruiting

55

Research Site

Salem, Oregon, United States, 97301

Actively Recruiting

56

Research Site

Hershey, Pennsylvania, United States, 17033

Actively Recruiting

57

Research Site

York, Pennsylvania, United States, 17403

Actively Recruiting

58

Research Site

Sioux Falls, South Dakota, United States, 57105

Actively Recruiting

59

Research Site

Chattanooga, Tennessee, United States, 37404

Actively Recruiting

60

Research Site

Nashville, Tennessee, United States, 37203

Actively Recruiting

61

Research Site

Fort Worth, Texas, United States, 76104

Actively Recruiting

62

Research Site

Houston, Texas, United States, 77090

Completed

63

Research Site

Kingwood, Texas, United States, 77339

Actively Recruiting

64

Research Site

Lubbock, Texas, United States, 79410

Actively Recruiting

65

Research Site

Round Rock, Texas, United States, 78665

Actively Recruiting

66

Research Site

Fairfax, Virginia, United States, 22031

Actively Recruiting

67

Research Site

Fredericksburg, Virginia, United States, 22408

Actively Recruiting

68

Research Site

Olympia, Washington, United States, 98506

Actively Recruiting

69

Research Site

Seattle, Washington, United States, 98101

Actively Recruiting

70

Research Site

Silverdale, Washington, United States, 98383

Withdrawn

71

Research Site

Spokane, Washington, United States, 99208

Actively Recruiting

72

Research Site

Tacoma, Washington, United States, 98405

Actively Recruiting

73

Research Site

Wenatchee, Washington, United States, 98801

Withdrawn

74

Research Site

Buenos Aires, Argentina, C1431FWO

Actively Recruiting

75

Research Site

CABA, Argentina, 1425

Actively Recruiting

76

Research Site

La Plata, Argentina, 1900

Withdrawn

77

Research Site

Pilar, Argentina, B1629ODT

Actively Recruiting

78

Research Site

Rosario, Argentina, S2000DEJ

Actively Recruiting

79

Research Site

Darlinghurst, Australia, 2010

Actively Recruiting

80

Research Site

Hyde Park, Australia, 4812

Actively Recruiting

81

Research Site

Southport, Australia, 4215

Actively Recruiting

82

Research Site

Wollongong, Australia, 2500

Actively Recruiting

83

Research Site

Innsbruck, Austria, 6020

Actively Recruiting

84

Research Site

Krems, Austria, 3500

Actively Recruiting

85

Research Site

Rankweil, Austria, 6830

Actively Recruiting

86

Research Site

Vienna, Austria, 1160

Actively Recruiting

87

Research Site

Vienna, Austria, 1210

Actively Recruiting

88

Research Site

Anderlecht, Belgium, 1070

Withdrawn

89

Research Site

Brussels, Belgium, 1160

Actively Recruiting

90

Research Site

Charleroi, Belgium, 6060

Actively Recruiting

91

Research Site

Kortrijk, Belgium, 8500

Actively Recruiting

92

Research Site

Ottignies, Belgium, 1340

Actively Recruiting

93

Research Site

Sint-Niklaas, Belgium, 9100

Withdrawn

94

Research Site

Barretos, Brazil, 14784-400

Actively Recruiting

95

Research Site

Florianópolis, Brazil, 88034-000

Actively Recruiting

96

Research Site

Ijuí, Brazil, 98700-000

Actively Recruiting

97

Research Site

Londrina, Brazil, 86015-520

Actively Recruiting

98

Research Site

Porto Alegre, Brazil, 91350-200

Actively Recruiting

99

Research Site

Salvador, Brazil, 40050 410

Actively Recruiting

100

Research Site

São Paulo, Brazil, 01246-000

Actively Recruiting

101

Research Site

São Paulo, Brazil, 05652-900

Actively Recruiting

102

Research Site

Taubaté, Brazil, 12030-200

Withdrawn

103

Research Site

Saint John, New Brunswick, Canada, E2L 4L2

Actively Recruiting

104

Research Site

Sydney, Nova Scotia, Canada, B1P 1P3

Actively Recruiting

105

Research Site

Hamilton, Ontario, Canada, L8V 1C3

Actively Recruiting

106

Research Site

Sault Ste. Marie, Ontario, Canada, P6A 0A8

Actively Recruiting

107

Research Site

Montreal, Quebec, Canada, H2X 0A9

Actively Recruiting

108

Research Site

Montreal, Quebec, Canada, H4A 3J1

Actively Recruiting

109

Research Site

Beijing, China, 100021

Actively Recruiting

110

Research Site

Beijing, China, 100029

Withdrawn

111

Research Site

Beijing, China, 100142

Actively Recruiting

112

Research Site

Beijing, China, 101149

Not Yet Recruiting

113

Research Site

Beijing, China, CN-100730

Actively Recruiting

114

Research Site

Changchun, China, 130012

Actively Recruiting

115

Research Site

Changde, China, 415000

Actively Recruiting

116

Research Site

Changsha, China, 410013

Actively Recruiting

117

Research Site

Chengdu, China, 610041

Actively Recruiting

118

Research Site

Chengdu, China, 610072

Actively Recruiting

119

Research Site

Chongqing, China, 400030

Actively Recruiting

120

Research Site

Dalian, China, 116001

Actively Recruiting

121

Research Site

Guangzhou, China, 510062

Actively Recruiting

122

Research Site

Guangzhou, China, 510100

Actively Recruiting

123

Research Site

Hangzhou, China, 310003

Actively Recruiting

124

Research Site

Hangzhou, China, 310016

Actively Recruiting

125

Research Site

Hangzhou, China, 310022

Actively Recruiting

126

Research Site

Harbin, China, 150081

Actively Recruiting

127

Research Site

Hefei, China, 230001

Actively Recruiting

128

Research Site

Hefei, China, 230601

Actively Recruiting

129

Research Site

Jinan, China, 250117

Actively Recruiting

130

Research Site

Kunming, China, 650118

Actively Recruiting

131

Research Site

Linhai, China, 317000

Actively Recruiting

132

Research Site

Linyi, China, 276001

Actively Recruiting

133

Research Site

Nanchang, China, 330008

Actively Recruiting

134

Research Site

Ningbo, China, 315010

Actively Recruiting

135

Research Site

Shanghai, China, 200030

Actively Recruiting

136

Research Site

Shanghai, China, 200032

Actively Recruiting

137

Research Site

Shanghai, China, 200433

Actively Recruiting

138

Research Site

Shenyang, China, 110004

Withdrawn

139

Research Site

Shenzhen, China, 518020

Actively Recruiting

140

Research Site

Taiyuan, China, 030000

Actively Recruiting

141

Research Site

Tianjin, China, 300050

Actively Recruiting

142

Research Site

Wenzhou, China, CN-325000

Actively Recruiting

143

Research Site

Wuhan, China, 430030

Suspended

144

Research Site

Xi'an, China, 710061

Actively Recruiting

145

Research Site

Yangzhou, China, 225001

Actively Recruiting

146

Research Site

Yueyang, China, 414000

Actively Recruiting

147

Research Site

Zhengzhou, China, 450008

Actively Recruiting

148

Research Site

Zhengzhou, China, 450052

Actively Recruiting

149

Research Site

Avignon, France, 84902

Actively Recruiting

150

Research Site

La Rochelle, France, 17019

Actively Recruiting

151

Research Site

Lyon, France, 69008

Actively Recruiting

152

Research Site

Nîmes, France, 30029

Actively Recruiting

153

Research Site

Rennes, France, 35033

Actively Recruiting

154

Research Site

Strasbourg, France, 67091

Actively Recruiting

155

Research Site

Suresnes, France, 92150

Actively Recruiting

156

Research Site

Toulon, France, 83800

Actively Recruiting

157

Research Site

Bad Berka, Germany, 99437

Actively Recruiting

158

Research Site

Berlin, Germany, 13125

Actively Recruiting

159

Research Site

Berlin, Germany, 13585

Actively Recruiting

160

Research Site

Bielefeld, Germany, 33611

Not Yet Recruiting

161

Research Site

Cologne, Germany, 51109

Actively Recruiting

162

Research Site

Esslingen am Neckar, Germany, 73730

Actively Recruiting

163

Research Site

Frankfurt, Germany, 60488

Actively Recruiting

164

Research Site

Gauting, Germany, 82131

Actively Recruiting

165

Research Site

Giessen, Germany, 35392

Actively Recruiting

166

Research Site

Großhansdorf, Germany, 22927

Actively Recruiting

167

Research Site

Hamburg, Germany, 20251

Actively Recruiting

168

Research Site

Hanover, Germany, 30459

Actively Recruiting

169

Research Site

Hanover, Germany, 30625

Actively Recruiting

170

Research Site

Heidelberg, Germany, 69126

Actively Recruiting

171

Research Site

Hemer, Germany, 58675

Actively Recruiting

172

Research Site

Homburg, Germany, 66424

Actively Recruiting

173

Research Site

Kassel, Germany, 34125

Actively Recruiting

174

Research Site

Kiel, Germany, 24105

Actively Recruiting

175

Research Site

Krefeld, Germany, 47805

Actively Recruiting

176

Research Site

Minden, Germany, 32429

Actively Recruiting

177

Research Site

Moers, Germany, 47441

Actively Recruiting

178

Research Site

München, Germany, 81925

Not Yet Recruiting

179

Research Site

Regensburg, Germany, 93053

Actively Recruiting

180

Research Site

Würzburg, Germany, 97067

Actively Recruiting

181

Research Site

Budapest, Hungary, 1083

Not Yet Recruiting

182

Research Site

Budapest, Hungary, 1121

Actively Recruiting

183

Research Site

Budapest, Hungary, 1122

Actively Recruiting

184

Research Site

Debrecen, Hungary, 4032

Actively Recruiting

185

Research Site

Gyöngyös, Hungary, 3200

Withdrawn

186

Research Site

Gyöngyös - Mátraháza, Hungary, 3200

Not Yet Recruiting

187

Research Site

Győr, Hungary, 9024

Actively Recruiting

188

Research Site

Pécs, Hungary, 7624

Actively Recruiting

189

Research Site

Székesfehérvár, Hungary, 8000

Not Yet Recruiting

190

Research Site

Törökbálint, Hungary, 2045

Actively Recruiting

191

Research Site

Calicut, India, 673601

Actively Recruiting

192

Research Site

Delhi, India, 110029

Actively Recruiting

193

Research Site

Kolkata, India, 700054

Withdrawn

194

Research Site

Madurai, India, 625107

Actively Recruiting

195

Research Site

Mumbai, India, 400012

Not Yet Recruiting

196

Research Site

Nashik, India, 422002

Actively Recruiting

197

Research Site

New Delhi, India, 110075

Withdrawn

198

Research Site

Puducherry, India, 605006

Withdrawn

199

Research Site

Surat, India, 395017

Actively Recruiting

200

Research Site

Varanasi, India, 221005

Actively Recruiting

201

Research Site

Florence, Italy, 50134

Actively Recruiting

202

Research Site

Monza, Italy, 20900

Actively Recruiting

203

Research Site

Orbassano, Italy, 10043

Actively Recruiting

204

Research Site

Padova, Italy, 35128

Actively Recruiting

205

Research Site

Peschiera del Garda, Italy, 37019

Actively Recruiting

206

Research Site

Roma, Italy, 00168

Actively Recruiting

207

Research Site

Amagasaki-shi, Japan, 660-8550

Actively Recruiting

208

Research Site

Bunkyō City, Japan, 113-8603

Actively Recruiting

209

Research Site

Chūōku, Japan, 104-0045

Actively Recruiting

210

Research Site

Fukuoka, Japan, 812-8582

Actively Recruiting

211

Research Site

Fukuoka, Japan, 814-0180

Actively Recruiting

212

Research Site

Hiroshima, Japan, 734-8551

Actively Recruiting

213

Research Site

Kawagoe-shi, Japan, 350-8550

Actively Recruiting

214

Research Site

Kawasaki-shi, Japan, 216-8511

Actively Recruiting

215

Research Site

Kitaadachi-gun, Japan, 362-0806

Actively Recruiting

216

Research Site

Kitakyushu-shi, Japan, 807-8555

Actively Recruiting

217

Research Site

Kobe, Japan, 650-0017

Actively Recruiting

218

Research Site

Kōtoku, Japan, 135-8550

Actively Recruiting

219

Research Site

Kumamoto, Japan, 860-8556

Actively Recruiting

220

Research Site

Kumamoto, Japan, 861-4193

Actively Recruiting

221

Research Site

Kyoto, Japan, 612-8555

Not Yet Recruiting

222

Research Site

Matsusaka-shi, Japan, 515-8544

Actively Recruiting

223

Research Site

Osaka, Japan, 541-8567

Actively Recruiting

224

Research Site

Ota-shi, Japan, 373-8550

Actively Recruiting

225

Research Site

Saitama-shi, Japan, 338-0001

Actively Recruiting

226

Research Site

Sakai, Japan, 590-0197

Actively Recruiting

227

Research Site

Sendai, Japan, 981-0914

Actively Recruiting

228

Research Site

Shinjuku-ku, Japan, 160-0023

Actively Recruiting

229

Research Site

Takaoka-shi, Japan, 933-8555

Actively Recruiting

230

Research Site

Yokohama, Japan, 232-0024

Actively Recruiting

231

Research Site

Yokohama, Japan, 241-8515

Actively Recruiting

232

Research Site

George Town, Malaysia, 10450

Actively Recruiting

233

Research Site

Johor Bahru, Malaysia, 81100

Actively Recruiting

234

Research Site

Kuala Lumpur, Malaysia, 59100

Actively Recruiting

235

Research Site

Alkmaar, Netherlands, 1815 JD

Actively Recruiting

236

Research Site

Ede, Netherlands, 6716 RP

Actively Recruiting

237

Research Site

Groningen, Netherlands, 9713 GZ

Withdrawn

238

Research Site

Leidschendam, Netherlands, 2262 BA

Actively Recruiting

239

Research Site

Veldhoven, Netherlands, 5504 DB

Actively Recruiting

240

Research Site

Zwolle, Netherlands, 8025 AB

Actively Recruiting

241

Research Site

Lima, Peru, 15036

Withdrawn

242

Research Site

Lima, Peru, 15102

Withdrawn

243

Research Site

Lima, Peru, 34

Withdrawn

244

Research Site

Lima, Peru, L27

Withdrawn

245

Research Site

Lima, Peru, LIMA 29

Withdrawn

246

Research Site

Lima, Peru, Lima39

Withdrawn

247

Research Site

Bialystok, Poland, 15-027

Withdrawn

248

Research Site

Biała Podlaska, Poland, 21-500

Suspended

249

Research Site

Bydgoszcz, Poland, 85-796

Suspended

250

Research Site

Bystra, Poland, 43-360

Actively Recruiting

251

Research Site

Lodz, Poland, 93-338

Actively Recruiting

252

Research Site

Poznan, Poland, 60-569

Actively Recruiting

253

Research Site

Warsaw, Poland, 04-141

Actively Recruiting

254

Research Site

San Juan, Puerto Rico, 00909

Actively Recruiting

255

Research Site

San Juan, Puerto Rico, 00918

Actively Recruiting

256

Research Site

Cheongju-si, South Korea, 28644

Actively Recruiting

257

Research Site

Incheon, South Korea, 21565

Actively Recruiting

258

Research Site

Seoul, South Korea, 03080

Actively Recruiting

259

Research Site

Seoul, South Korea, 03722

Actively Recruiting

260

Research Site

Seoul, South Korea, 05505

Actively Recruiting

261

Research Site

Seoul, South Korea, 06351

Actively Recruiting

262

Research Site

Suwon, South Korea, 16247

Actively Recruiting

263

Research Site

Suwon, South Korea, 16499

Actively Recruiting

264

Research Site

Barcelona, Spain, 8035

Actively Recruiting

265

Research Site

Las Palmas de Gran Canaria, Spain, 35016

Actively Recruiting

266

Research Site

Lleida, Spain, 25198

Actively Recruiting

267

Research Site

Madrid, Spain, 28007

Actively Recruiting

268

Research Site

Madrid, Spain, 28034

Actively Recruiting

269

Research Site

Majadahonda, Spain, 28222

Actively Recruiting

270

Research Site

Seville, Spain, 41013

Actively Recruiting

271

Research Site

Kaohsiung City, Taiwan, 80756

Actively Recruiting

272

Research Site

Kaohsiung City, Taiwan, 824

Actively Recruiting

273

Research Site

New Taipei City, Taiwan, 220

Actively Recruiting

274

Research Site

New Taipei City, Taiwan, 23561

Actively Recruiting

275

Research Site

Taichung, Taiwan, 402

Actively Recruiting

276

Research Site

Taichung, Taiwan, 40705

Actively Recruiting

277

Research Site

Tainan, Taiwan, 73657

Actively Recruiting

278

Research Site

Taoyuan, Taiwan, 333

Actively Recruiting

279

Research Site

Bangkok, Thailand, 10700

Actively Recruiting

280

Research Site

Chiang Mai, Thailand, 50200

Actively Recruiting

281

Research Site

Dusit, Thailand, 10300

Actively Recruiting

282

Research Site

Nakhon Ratchasima, Thailand, 30000

Actively Recruiting

283

Research Site

Songkhla, Thailand, 90110

Actively Recruiting

284

Research Site

Ankara, Turkey (Türkiye), 6500

Actively Recruiting

285

Research Site

Antalya, Turkey (Türkiye), 07059

Actively Recruiting

286

Research Site

Istanbul, Turkey (Türkiye), 34098

Actively Recruiting

287

Research Site

Yenimahalle, Turkey (Türkiye), 06170

Actively Recruiting

288

Research Site

Aberdeen, United Kingdom, AB25 2ZN

Actively Recruiting

289

Research Site

Cambridge, United Kingdom, CB2 0QQ

Actively Recruiting

290

Research Site

Edinburgh, United Kingdom, EH4 2XU

Actively Recruiting

291

Research Site

Exeter, United Kingdom, EX2 5DW

Withdrawn

292

Research Site

Greater London, United Kingdom, SW3 6JJ

Actively Recruiting

293

Research Site

London, United Kingdom, EC1A 7BE

Actively Recruiting

294

Research Site

London, United Kingdom, SE1 9RT

Actively Recruiting

295

Research Site

Manchester, United Kingdom, M20 4BX

Actively Recruiting

296

Research Site

Newcastle upon Tyne, United Kingdom, NE7 7AF

Actively Recruiting

297

Research Site

Preston, United Kingdom, PR2 9HT

Actively Recruiting

298

Research Site

Can Tho, Vietnam, 900000

Actively Recruiting

299

Research Site

Hanoi, Vietnam, 100000

Actively Recruiting

300

Research Site

Ho Chi Minh City, Vietnam, 700000

Actively Recruiting

301

Research Site

Vinh, Vietnam, 460000

Actively Recruiting

Loading map...

Research Team

A

AstraZeneca Clinical Study Information Center

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) | DecenTrialz